This does not appear to be universal, however, because in the MRL/lpr model of murine SLE, the absence of IFNAR not only fails to prevent the disease but it leads to accelerated autoimmunity, whereas administration of IFN-I increases survival [42], [43]. Here, IFNAR1 is linked to systemic lupus erythematosus.